Hi Danagram, could you please elaborate on your comment; ‘The less news before FDA approval the better …’, my thinking is any sp sensitive news, via ASX, would be beneficial to the sp. Why: Mercer, future, entry points at a higher sp, any potential CR, at a higher sp, options and @ $8 ‘snapped’ up, that make sense?
CRs, Mercer entry points at North of current sp done at a higher sp?, sentiment factor in lead up too FDA approval?
Imo, not advice.
Watchthisspace tweet, page-59
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
